title: Dry blending process scale-up for a very low dose drug candidate.
authors.affiliation: DuPont Pharmaceuticals Company, Wilmington, DE, USA. lei-shu.wu@dupontpharma.com
authors.forename: L S
authors.initials: LS
authors.lastname: Wu
authors.forename: J
authors.initials: J
authors.lastname: Pang
authors.forename: J G
authors.initials: JG
authors.lastname: Chen
authors.forename: M A
authors.initials: MA
authors.lastname: Hussain
mesh_terms: D002214:Capsules / Q000737:chemistry / Q000378:metabolism; D002626:Chemistry, Pharmaceutical / Q000639:trends; D004304:Dosage Forms; D004339:Drug Compounding / Q000639:trends*; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000378:metabolism*
chemical_list: D002214:Capsules; D004304:Dosage Forms; D004364:Pharmaceutical Preparations